BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2597525)

  • 21. The relationship between cardiac output and access flow during hemodialysis.
    Pandeya S; Lindsay RM
    ASAIO J; 1999; 45(3):135-8. PubMed ID: 10360711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational analysis of blood volume dynamics during hemodialysis.
    Lopot F; Kotyk P
    Int J Artif Organs; 1997 Feb; 20(2):91-5. PubMed ID: 9093886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of profiled hemodialysis.
    Colì L; Bonomini M; La Manna G; Dalmastri V; Ursino M; Ivanovich P; Bonomini V
    Artif Organs; 1998 Sep; 22(9):724-30. PubMed ID: 9754456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ultrafiltration on body fluid volumes and transcapillary colloid osmotic gradient in hemodialysis patients.
    Fauchald P
    Contrib Nephrol; 1989; 74():170-5. PubMed ID: 2702136
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemodynamics during hemodialysis, sequential ultrafiltration and hemofiltration.
    Hampl H; Paeprer H; Unger V; Kessel MW
    J Dial; 1979; 3(1):51-71. PubMed ID: 381341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large surface area dialysis; innovations and patient management.
    Smith LJ
    Nurs Clin North Am; 1975 Sep; 10(3):481-90. PubMed ID: 1041630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrafiltration and backfiltration during hemodialysis.
    Ofsthun NJ; Leypoldt JK
    Artif Organs; 1995 Nov; 19(11):1143-61. PubMed ID: 8579527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotension.
    Aronoff GR
    Semin Dial; 2017 Nov; 30(6):489-491. PubMed ID: 28666075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactive parathyroid hormone after volume change in normo- and hypotensive hemodialysis patients.
    Heintz B; Mann H; Kierdorf H; Königs F; Nelson K; Kirsten R; Heicke N; Wieland D; Gladziwa U; Sieberth HG
    Clin Nephrol; 1992 Mar; 37(3):140-4. PubMed ID: 1563118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high hematocrit and high blood flow rates on transmembrane pressure and ultrafiltration rate in hemodialysis.
    Ofsthun NJ; Jensen JC; Kray M
    Blood Purif; 1991; 9(3):169-76. PubMed ID: 1801859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which fluid space is affected by ultrafiltration during hemodiafiltration?
    Tapolyai MB; Faludi M; Fülöp T; Dossabhoy NR; Szombathelyi A; Berta K
    Hemodial Int; 2014 Apr; 18(2):384-90. PubMed ID: 24438545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hemodynamic effect of calcium ion concentration in the infusate during predilution hemofiltration in chronic renal failure.
    Karamperis N; Sloth E; Jensen JD
    Am J Kidney Dis; 2005 Sep; 46(3):470-80. PubMed ID: 16129209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow continuous hemofiltration and slow continuous ultrafiltration.
    Paganini EP
    ASAIO Trans; 1988; 34(1):63-6. PubMed ID: 3377916
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is the plasma ANP level an index of volume expansion in dialysis patients?].
    Talartschik J; Eisenhauer T; Voth E; Sold G; Scheler F
    Z Kardiol; 1988; 77 Suppl 2():72-7. PubMed ID: 2970178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of B-type natriuretic peptide to assess volume status in dialysis patients.
    Codognotto M; Piccoli A
    Am Heart J; 2007 Nov; 154(5):e31. PubMed ID: 17967574
    [No Abstract]   [Full Text] [Related]  

  • 38. Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass.
    Heath M; Barbeito A; Welsby I; Maxwell C; Iribarne A; Raghunathan K
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):162-8. PubMed ID: 25857672
    [No Abstract]   [Full Text] [Related]  

  • 39. Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis.
    Bonello M; House AA; Cruz D; Asuman Y; Andrikos E; Petras D; Strazzabosco M; Ronco F; Brendolan A; Crepaldi C; Nalesso F; Ronco C
    Int J Artif Organs; 2007 Dec; 30(12):1098-108. PubMed ID: 18203072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamics in hemofiltration.
    Baldamus CA; Ernst W; Lysaght MJ; Shaldon S; Koch KM
    Int J Artif Organs; 1983 Jan; 6(1):27-31. PubMed ID: 6840884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.